PHYTOPTION LLC
Proprietary formulation technology that solubilizes poorly water-soluble active ingredients for pharmaceuticals, food, and personal care products
- Sector
- Materials
- Total capital
- $910K
- Federal grants
- $910K
- 1 award · 2016
- Rank in peer group#3 of 90
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 9 pending · first 2016
- Rank in peer group#19 of 90
Capital timeline
Latest events
- Federal grantNSF · Phase II · SBIR Phase II: New ingredients technology to enhance the safety, quality, and value of active substances for pharmaceuticals, food, and personal care$910K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 90 peers
Line = medianMaterials · Material
- Federal grants#3 · top 3%
- Granted patents#19 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 10- PendingOhpp-formulated Niclosamide To Treat Influenza AUSPTOApplication 18017396
- PendingEmulsifiers And The Uses ThereofUSPTOApplication 17072200
- GrantedPhytoglycogen-Based Compositions, Materials and MethodsUSPTOUS 9,422,585
Show all 10 patent records
- Ohpp-formulated Niclosamide To Treat Influenza ASep 21, 2023 · Application 18017396Pending
- Emulsifiers And The Uses ThereofFeb 11, 2021 · Application 17072200Pending
- Phytoglycogen-Based Compositions, Materials and MethodsAug 23, 2016 · US 9,422,585Granted
- Emulsifiers And The Uses ThereofApplication PCTUS2019028411Pending
- Emulsifiers And The Uses ThereofApplication 62731960Pending
- Emulsifiers And The Uses ThereofApplication 62698193Pending
- Emulsifiers And The Uses ThereofApplication 62659950Pending
- Phytoglycogen-based Compositions, Materials And MethodsApplication PCTUS2012060249Pending
- Ohpp-formulated Niclosamide To Treat SARS-COV-2, Other Viral Diseases, And CancersApplication PCTUS2021042868Pending
- Ohpp-formulated Niclosamide To Treat SARS-COV-2, Other Viral Diseases, And CancerApplication 63181612Pending
Related companies, and why
- Cruz Foam, Inc.Similar federal contract value in Materials · null in contracts
- Spoke Sciences, Inc.Similar federal contract value in Materials · null in contracts
- ALCHEMY COATINGS INCSimilar federal contract value in Materials · null in contracts
- Acuity Polymers, Inc.Similar federal contract value in Materials · null in contracts
- Inprentus, Inc.Similar federal contract value in Materials · null in contracts
- Ipsum Nano, LLCSimilar federal contract value in Materials · null in contracts
Regulatory activity · Materials
- Eliminating Regulations Establishing Fellowships in Laboratory Standardization and Testing for Foreign CitizensNational Institute of Standards and Technology
- Eliminating Obsolete Marking Requirements for Toy, Look-Alike, and Imitation FirearmsNational Institute of Standards and Technology
- Eliminating Obsolete Regulations Related to the Advanced Technology Program and the Technology Innovation ProgramNational Institute of Standards and Technology
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .